Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


Among the great diseases of pregnancy, preeclampsia and spontaneous preterm birth extract an exceedingly high degree of maternal and neonatal morbidity yet prediction of their potential occurrence in any given pregnancy remains frustratingly elusive. This talk will review the basis for why such predictive tests have been so elusive and the advances of our group in utilizing cell free RNA as a potential means to stratifying a patient’s risk of pregnancy complication. Finally, consideration will be given to the potential practical and clinical implications that such predictive tests might bring.



Dr. McElrath is Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and a Professor of Epidemiology at the Harvard School of Public Health. He serves as a senior attending in Maternal-Fetal Medicine at Boston’s Brigham and Women’s Hospital where he is the director of the Preterm Birth Clinic. He is founder and Principal Investigator of the Boston based LIFECODES birth cohort and has research interests in the epidemiology of preterm birth particularly the development of novel biomarkers to classify the risk of preeclampsia and related adverse birth outcomes.